Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIB or IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00234052
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 51
Testing effectiveness (Phase 2)Study completedNCT02581943
What this trial is testing

Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 43
Testing effectiveness (Phase 2)Ended earlyNCT00346645
What this trial is testing

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

Who this might be right for
STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER
Gustave Roussy, Cancer Campus, Grand Paris 46
Very early researchActive Not RecruitingNCT05041153
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Gastric Cancer AJCC v8+30 more
M.D. Anderson Cancer Center 15
Very early researchActive Not RecruitingNCT02659241
What this trial is testing

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+19 more
M.D. Anderson Cancer Center 38
Early research (Phase 1)Ended earlyNCT01574222
What this trial is testing

A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
VA Office of Research and Development 1
Post-approval studies (Phase 4)UnknownNCT04814056
What this trial is testing

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

Who this might be right for
NRG1-fused Non-small Cell Lung Cancer
Shanghai Chest Hospital 15
Early research (Phase 1)Study completedNCT00496275
What this trial is testing

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 17
Testing effectiveness (Phase 2)Study completedNCT02902029
What this trial is testing

Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
University Hospital, Essen 186
Testing effectiveness (Phase 2)Study completedNCT00874107
What this trial is testing

Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
HiberCell, Inc. 90
Early research (Phase 1)Ended earlyNCT01835184
What this trial is testing

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+3 more
National Cancer Institute (NCI) 5
Not applicableStudy completedNCT00079170
What this trial is testing

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003927
What this trial is testing

Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 15
Not applicableStudy completedNCT00084669
What this trial is testing

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerHot FlashesSleep Disorders
Massachusetts General Hospital 119
Testing effectiveness (Phase 2)Ended earlyNCT04396535
What this trial is testing

Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more
Mayo Clinic 10
Large-scale testing (Phase 3)Ended earlyNCT00662597
What this trial is testing

ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 1,285
Large-scale testing (Phase 3)Study completedNCT00043888
What this trial is testing

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Who this might be right for
HIV Infections
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Ended earlyNCT00452140
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04200443
What this trial is testing

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Soft Tissue SarcomaStage III Uterine Corpus Leiomyosarcoma AJCC v8+8 more
City of Hope Medical Center 96
Testing effectiveness (Phase 2)Temporarily pausedNCT01088620
What this trial is testing

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
WiSP Wissenschaftlicher Service Pharma GmbH 134
Next Page